ZIMMER BIOMET, INC.

Lobbying for ZIMMER BIOMET, INC.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Expenses

$170,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment

Trade (domestic/foreign)

Trade Issues/Policy

Taxation/Internal Revenue Code

Tax Issues; ACA Tax Credit

Health Issues

Assorted issues related to the FDA

Chemicals/Chemical Industry

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.